Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

10 results
Display

Gefitinib Trial in a Fanconi's Anemia Patient with Multiple Squamous Cell Carcinomas and Hepatocellular Carcinoma

Jung HS, Byun GW, Lee KE, Mun YC, Nam SH, Kwon JM, Lee SN, Im SA, Seong CM, Lee SN

  • Cancer Res Treat.
  • 2005 Dec;37(6):370-373.
FA (Fanconi's Anemia) is an autosomal recessive disorder that is characterized by pancytopenia with bone marrow hypoplasia, diverse congenital abnormalities and an increased predisposition towards malignancy. The mainstay of the...
The Role of Radiation Therapy for the Extramammary Paget's Disease of the Vulva ; Experience of 3 Cases

Son SH, Lee JS, Kim YS, Ryu MR, Chung SM, Namkoong S, Han GT, Lee HJ, Yoon SC

  • Cancer Res Treat.
  • 2005 Dec;37(6):365-369.
We have experienced three cases of extramammary Paget's disease (EMPD) of the vulva that received radiation therapy (RT). Here, we analyze the efficacy of RT and include a literature survey....
Overexpression of Metastatic Tumor Antigen in Osteosarcoma: Comparison between Conventional High-Grade and Central Low-Grade Osteosarcoma

Park HR, Jung WW, Kim HS, Bacchini P, Bertoni F, Park YK

  • Cancer Res Treat.
  • 2005 Dec;37(6):360-364.
PURPOSE: The metastatic tumor antigen (MTA) gene is a recently identified metastasis-associated gene which has implications in the signal transduction or regulation of gene expression. However, the expression of MTA...
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer

Cho YR, Kwon HC, Suh SH, Lee JH, Kim SH, Choi HJ, Lee HS, Roh MS, Hwang TH, Kim JS, Kim HJ

  • Cancer Res Treat.
  • 2005 Dec;37(6):354-359.
PURPOSE: The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes. MMPs are known to be involved in tumor invasion, and several have been implicated in tumor prognosis. The aim...
A Multi-Center, Phase II Clinical Trial of Padexol(TM) (Paclitaxel) and Cisplatin for Patients Suffering with Advanced Gastric Cancer

Kim MK, Lee KH, Hyun MS, Do YR, Song HS, Lee WS, Park KU, Baek JH, Kim JG

  • Cancer Res Treat.
  • 2005 Dec;37(6):349-353.
PURPOSE: We conducted a multi-center, phase II trial to evaluate the efficacy and safety of using Padexol (a paclitaxel formulation) combined with cisplatin for the patients suffering with advanced gastric...
Clinical Experience of Patients with Ductal Carcinoma In Situ of the Breast Treated with Breast-Conserving Surgery plus Radiotherapy: A Preliminary Report

Jang JY, Ryu MR, Kim SW, Kay CS, Kim YS, Oh YK, Kwon HC, Yoon SC, Park WC, Song BJ, Oh SJ, Jung SS, Won JM, Kim SN, Chung SM

  • Cancer Res Treat.
  • 2005 Dec;37(6):344-348.
PURPOSE: Breast-conserving therapy (BCT) is a practical alternative to mastectomy for treating ductal carcinoma in situ (DCIS). We reviewed our experience for treating patients with DCIS of the breast to...
The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m2) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated with Platinum-based Chemotherapy

Shim BY, Kim CH, Song SH, Ahn MI, Hong EJ, Kim SW, Kim S, Jo MS, Cho DG, Cho KD, Yoo J, Kim HK

  • Cancer Res Treat.
  • 2005 Dec;37(6):339-343.
PURPOSE: When used in the second-line setting, single- agent chemotherapy has produced response rates of more than 10% or median survival times greater than 4 months. We studied the safety...
Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer

Lee NS, Park HS, Won JH, Hong DS, Uh ST, Lee SJ, Kim JH, Kim SK, Ahn MJ, Choi JH, Yang SC, Lee JA, Lee KS, Yim CY, Lee YC, Kim CS, Lee MH, Jung KD, Moon H, Lee YS

  • Cancer Res Treat.
  • 2005 Dec;37(6):332-338.
PURPOSE: We prospectively conducted a multi-center, open-label, randomized phase II trial to compare the efficacy and safety of docetaxel plus cisplatin (DC) and etoposide plus cisplatin (EC) for treating advanced...
Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence Database

Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, Noh HI, Lee JK, Pisani P, Park JG, Ahn YO, Lee SY, Lee CW, Woo ZH, Lee TY, Choi JS, Yoo CI, Bae JM

  • Cancer Res Treat.
  • 2005 Dec;37(6):325-331.
PURPOSE: The first Korean national population- based cancer registry using nationwide hospital-based recording system and the regional cancer registries provided the source to obtain national cancer incidences for the period...
The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis

Yim EK, Park JS

  • Cancer Res Treat.
  • 2005 Dec;37(6):319-324.
Cervical cancer is one of the leading world causes of cancer morbidity and mortality in woman, with more than 98% related to a human papillomavirus (HPV) infection origin. Infection with...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr